Carvacrol, a Food-Additive, Provides Neuroprotection on Focal Cerebral Ischemia/Reperfusion Injury in Mice
Open Access
- 16 March 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (3), e33584
- https://doi.org/10.1371/journal.pone.0033584
Abstract
Carvacrol (CAR), a naturally occurring monoterpenic phenol and food additive, has been shown to have antimicrobials, antitumor, and antidepressant-like activities. A previous study demonstrated that CAR has the ability to protect liver against ischemia/reperfusion injury in rats. In this study, we investigated the protective effects of CAR on cerebral ischemia/reperfusion injury in a middle cerebral artery occlusion mouse model. We found that CAR (50 mg/kg) significantly reduced infarct volume and improved neurological deficits after 75 min of ischemia and 24 h of reperfusion. This neuroprotection was in a dose-dependent manner. Post-treatment with CAR still provided protection on infarct volume when it was administered intraperitoneally at 2 h after reperfusion; however, intracerebroventricular post-treatment reduced infarct volume even when the mice were treated with CAR at 6 h after reperfusion. These findings indicated that CAR has an extended therapeutic window, but delivery strategies may affect the protective effects of CAR. Further, we found that CAR significantly decreased the level of cleaved caspase-3, a marker of apoptosis, suggesting the anti-apoptotic activity of CAR. Finally, our data indicated that CAR treatment increased the level of phosphorylated Akt and the neuroprotection of CAR was reversed by a PI3K inhibitor LY-294002, demonstrating the involvement of the PI3K/Akt pathway in the anti-apoptotic mechanisms of CAR. Due to its safety and wide use in the food industry, CAR is a promising agent to be translated into clinical trials.This publication has 39 references indexed in Scilit:
- Anti-proliferative and pro-apoptotic effect of carvacrol on human hepatocellular carcinoma cell line HepG-2Cytotechnology, 2011
- Essential Oils Composition and Antioxidant Properties of ThreeThymusSpeciesEvidence-Based Complementary and Alternative Medicine, 2011
- Myrtenal inhibits acetylcholinesterase, a known Alzheimer targetJournal of Pharmacy and Pharmacology, 2011
- Investigational Therapies for Ischemic Stroke: Neuroprotection and NeurorecoveryNeurotherapeutics, 2011
- Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia/reperfusion injuryBrain Research, 2010
- Fungicidal activity of thymol and carvacrol by disrupting ergosterol biosynthesis and membrane integrity against CandidaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2010
- Neuroprotection in acute ischemic stroke – current statusJournal of Cellular and Molecular Medicine, 2010
- Carvacrol, a component of thyme oil, activates PPARα and γ and suppresses COX-2 expressionJournal of Lipid Research, 2010
- Carvacrol is a novel inhibitor of Drosophila TRPL and mammalian TRPM7 channelsCell Calcium, 2009
- Neuroprotective effect of humanin on cerebral ischemia/reperfusion injury is mediated by a PI3K/Akt pathwayBrain Research, 2008